Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation

被引:138
作者
Gu, Zhimin [1 ,2 ,3 ]
Liu, Yuxuan [1 ,2 ,3 ]
Cai, Feng [1 ]
Patrick, McKenzie [1 ,2 ,3 ]
Zmajkovic, Jakub [4 ]
Cao, Hui [1 ,2 ,3 ]
Zhang, Yuannyu [1 ,2 ,3 ]
Tasdogan, Alpaslan [1 ]
Chen, Mingyi [5 ]
Qi, Le [1 ]
Liu, Xin [1 ,2 ,3 ]
Li, Kailong [1 ,2 ,3 ]
Lyu, Junhua [1 ,2 ,3 ]
Dickerson, Kathryn E. [1 ,2 ,3 ]
Chen, Weina [5 ]
Ni, Min [1 ]
Merritt, Matthew E. [6 ]
Morrison, Sean J. [1 ,7 ]
Skoda, Radek C. [4 ]
DeBerardinis, Ralph J. [1 ,7 ]
Xu, Jian [1 ,2 ,3 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Childrens Med Ctr, Res Inst, Dallas, TX 75390 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Harold C Simmons Comprehens Canc Ctr, Dallas, TX USA
[3] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX USA
[4] Univ Hosp Basel, Dept Biomed, Basel, Switzerland
[5] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX USA
[6] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Miami, FL USA
[7] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX USA
关键词
METHYLTRANSFERASE GENE EZH2; AMINO-ACID-METABOLISM; SOMATIC MUTATIONS; STEM-CELLS; PATHOGENESIS; PROGRESSION; AML; DIFFERENTIATION; PROLIFERATION; MYELOFIBROSIS;
D O I
10.1158/2159-8290.CD-19-0152
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epigenetic gene regulation and metabolism are highly intertwined, yet little is known about whether altered epigenetics influence cellular metabolism during cancer progression. Here, we show that EZH2 and NRAS(G12D) mutations cooperatively induce progression of myeloproliferative neoplasms to highly penetrant, transplantable, and lethal myeloid leukemias in mice. EZH1, an EZH2 homolog, is indispensable for EZH2-deficient leukemia-initiating cells and constitutes an epigenetic vulnerability. BCAT1, which catalyzes the reversible transamination of branched-chain amino acids (BCAA), is repressed by EZH2 in normal hematopoiesis and aberrantly activated in EZH2-deficient myeloid neoplasms in mice and humans. BCAT1 reactivation cooperates with NRAS(G12D) to sustain intracellular BCAA pools, resulting in enhanced mTOR signaling in EZH2-deficient leukemia cells. Genetic and pharmacologic inhibition of BCAT1 selectively impairs EZH2-deficient leuke-miainitiating cells and constitutes a metabolic vulnerability. Hence, epigenetic alterations rewire intracellular metabolism during leukemic transformation, causing epigenetic and metabolic vulnerabilities in cancer-initiating cells. SIGNIFICANCE: EZH2 inactivation and oncogenic NRAS cooperate to induce leukemic transformation of myeloproliferative neoplasms by activating BCAT1 to enhance BCAA metabolism and mTOR signaling. We uncover a mechanism by which epigenetic alterations rewire metabolism during cancer progression, causing epigenetic and metabolic liabilities in cancer-initiating cells that may be exploited as potential therapeutics.
引用
收藏
页码:1228 / 1247
页数:20
相关论文
共 68 条
[1]   ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression [J].
Abdel-Wahab, Omar ;
Adli, Mazhar ;
LaFave, Lindsay M. ;
Gao, Jie ;
Hricik, Todd ;
Shih, Alan H. ;
Pandey, Suveg ;
Patel, Jay P. ;
Chung, Young Rock ;
Koche, Richard ;
Perna, Fabiana ;
Zhao, Xinyang ;
Taylor, Jordan E. ;
Park, Christopher Y. ;
Carroll, Martin ;
Melnick, Ari ;
Nimer, Stephen D. ;
Jaffe, Jacob D. ;
Aifantis, Iannis ;
Bernstein, Bradley E. ;
Levine, Ross L. .
CANCER CELL, 2012, 22 (02) :180-193
[2]   Cytosolic Branched Chain Aminotransferase (BCATc) Regulates mTORC1 Signaling and Glycolytic Metabolism in CD4+ T Cells [J].
Ananieva, Elitsa A. ;
Patel, Chirag H. ;
Drake, Charles H. ;
Powell, Jonathan D. ;
Hutson, Susan M. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (27) :18793-18804
[3]   The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia [J].
Arber, Daniel A. ;
Orazi, Attilio ;
Hasserjian, Robert ;
Thiele, Jurgen ;
Borowitz, Michael J. ;
Le Beau, Michelle M. ;
Bloomfield, Clara D. ;
Cazzola, Mario ;
Vardiman, James W. .
BLOOD, 2016, 127 (20) :2391-2405
[4]   Implications of NRAS mutations in AML:: a study of 2502 patients [J].
Bacher, Ulrike ;
Haferlach, Torsten ;
Schoch, Claudia ;
Kern, Wolfgang ;
Schnittger, Susanne .
BLOOD, 2006, 107 (10) :3847-3853
[5]   Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm [J].
Beer, Philip A. ;
Delhommeau, Francois ;
LeCouedic, Jean-Pierre ;
Dawson, Mark A. ;
Chen, Edwin ;
Bareford, David ;
Kusec, Rajko ;
McMullin, Mary Frances ;
Harrison, Claire N. ;
Vannucchi, Alessandro M. ;
Vainchenker, William ;
Green, Anthony R. .
BLOOD, 2010, 115 (14) :2891-2900
[6]   Ezh2 and Runx1 Mutations Collaborate to Initiate Lympho-Myeloid Leukemia in Early Thymic Progenitors [J].
Booth, Christopher A. G. ;
Barkas, Nikolaos ;
Neo, Wen Hao ;
Boukarabila, Hanane ;
Soilleux, Elizabeth J. ;
Giotopoulos, George ;
Farnoud, Noushin ;
Giustacchini, Alice ;
Ashley, Neil ;
Carrelha, Joana ;
Jamieson, Lauren ;
Atkinson, Deborah ;
Bouriez-Jones, Tiphaine ;
Prinjha, Rab K. ;
Milne, Thomas A. ;
Teachey, David T. ;
Papaemmanuil, Elli ;
Huntly, Brian J. P. ;
Jacobsen, Sten Eirik W. ;
Mead, Adam J. .
CANCER CELL, 2018, 33 (02) :274-+
[7]   Cancer Cell Metabolism: One Hallmark, Many Faces [J].
Cantor, Jason R. ;
Sabatini, David M. .
CANCER DISCOVERY, 2012, 2 (10) :881-898
[8]   Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network [J].
Caye, Aurelie ;
Strullu, Marion ;
Guidez, Fabien ;
Cassinat, Bruno ;
Gazal, Steven ;
Fenneteau, Odile ;
Lainey, Elodie ;
Nouri, Kazem ;
Nakhaei-Rad, Saeideh ;
Dvorsky, Radovan ;
Lachenaud, Julie ;
Pereira, Sabrina ;
Vivent, Jocelyne ;
Verger, Emmanuelle ;
Vidaud, Dominique ;
Galambrun, Claire ;
Picard, Capucine ;
Petit, Arnaud ;
Contet, Audrey ;
Poiree, Marilyne ;
Sirvent, Nicolas ;
Mechinaud, Francoise ;
Adjaoud, Dalila ;
Paillard, Catherine ;
Nelken, Brigitte ;
Reguerre, Yves ;
Bertrand, Yves ;
Haeussinger, Dieter ;
Dalle, Jean-Hugues ;
Ahmadian, Mohammad Reza ;
Baruchel, Andre ;
Chomienne, Christine ;
Cave, Helene .
NATURE GENETICS, 2015, 47 (11) :1334-+
[9]   Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders [J].
Ernst, Thomas ;
Chase, Andrew J. ;
Score, Joannah ;
Hidalgo-Curtis, Claire E. ;
Bryant, Catherine ;
Jones, Amy V. ;
Waghorn, Katherine ;
Zoi, Katerina ;
Ross, Fiona M. ;
Reiter, Andreas ;
Hochhaus, Andreas ;
Drexler, Hans G. ;
Duncombe, Andrew ;
Cervantes, Francisco ;
Oscier, David ;
Boultwood, Jacqueline ;
Grand, Francis H. ;
Cross, Nicholas C. P. .
NATURE GENETICS, 2010, 42 (08) :722-U109
[10]   Promoting Health and Longevity through Diet: From Model Organisms to Humans [J].
Fontana, Luigi ;
Partridge, Linda .
CELL, 2015, 161 (01) :106-118